Stella Pharma Corporation (TYO:4888)
Japan flag Japan · Delayed Price · Currency is JPY
431.00
-1.00 (-0.23%)
Nov 18, 2026, 10:00 AM JST

Stella Pharma Revenue

Stella Pharma had revenue of 83.00M JPY in the quarter ending September 30, 2026, a decrease of -23.15%. This brings the company's total for the last twelve months to 298.00M, down -69.96% year-over-year. In the fiscal year ending March 31, 2026, Stella Pharma had annual revenue of 323.00M, down -66.39%. That makes Stella Pharma the 42,548th largest company in the world by revenue and 3,854th in Japan.

Revenue (ttm)
298.00M
Revenue Growth
-69.96%
P/S Ratio
55.14
Revenue / Employee
6.34M
Employees
47
Market Cap
16.39B

Revenue Chart

Revenue by Geography

  • China 629.97M 65.5%
  • Japan 331.09M 34.5%
Fiscal year ended Mar 31, 2024 See the full Stella Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026323.00M-638.00M-66.39%
Mar 31, 2025961.00M692.00M257.25%
Mar 31, 2024269.00M40.00M17.47%
Mar 31, 2023229.00M129.00M129.00%
Mar 31, 2022100.00M-105.00M-51.22%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.